• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Virotherapy against malignant glioma stem cells.病毒疗法对抗恶性神经胶质瘤干细胞。
Cancer Lett. 2010 Mar 1;289(1):1-10. doi: 10.1016/j.canlet.2009.04.045. Epub 2009 Jul 29.
2
Cancer stem cells: the final frontier for glioma virotherapy.癌症干细胞:神经胶质瘤病毒疗法的最后边界。
Stem Cell Rev Rep. 2011 Mar;7(1):119-29. doi: 10.1007/s12015-010-9132-7.
3
Mesenchymal stem cells enhance the oncolytic effect of Newcastle disease virus in glioma cells and glioma stem cells via the secretion of TRAIL.间充质干细胞通过分泌肿瘤坏死因子相关凋亡诱导配体(TRAIL)增强新城疫病毒对胶质瘤细胞和胶质瘤干细胞的溶瘤作用。
Stem Cell Res Ther. 2016 Oct 10;7(1):149. doi: 10.1186/s13287-016-0414-0.
4
Varicella zoster virus infection of malignant glioma cell cultures: a new candidate for oncolytic virotherapy?水痘带状疱疹病毒感染恶性神经胶质瘤细胞培养物:溶瘤病毒治疗的新候选者?
Anticancer Res. 2012 Apr;32(4):1137-44.
5
Oncolytic Virotherapy for the Treatment of Malignant Glioma.溶瘤病毒疗法治疗恶性胶质瘤
Neurotherapeutics. 2017 Apr;14(2):333-344. doi: 10.1007/s13311-017-0516-0.
6
A comparative study of neural and mesenchymal stem cell-based carriers for oncolytic adenovirus in a model of malignant glioma.神经干细胞和间充质干细胞载体在恶性神经胶质瘤模型中用于溶瘤腺病毒的比较研究。
Mol Pharm. 2011 Oct 3;8(5):1559-72. doi: 10.1021/mp200161f. Epub 2011 Jun 30.
7
Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo.神经干细胞靶向颅内胶质瘤以在体内递送溶瘤腺病毒。
Gene Ther. 2009 Feb;16(2):262-78. doi: 10.1038/gt.2008.165. Epub 2008 Dec 11.
8
Systemic administration of mesenchymal stem cells loaded with a novel oncolytic adenovirus carrying IL-24/endostatin enhances glioma therapy.携带IL-24/内皮抑素的新型溶瘤腺病毒负载的间充质干细胞的全身给药增强了胶质瘤治疗效果。
Cancer Lett. 2021 Jul 1;509:26-38. doi: 10.1016/j.canlet.2021.03.027. Epub 2021 Apr 2.
9
Targeting pediatric cancer stem cells with oncolytic virotherapy.用溶瘤病毒疗法靶向小儿癌干细胞。
Pediatr Res. 2012 Apr;71(4 Pt 2):500-10. doi: 10.1038/pr.2011.58. Epub 2012 Feb 15.
10
Oncolytic adenoviral therapy for glioblastoma multiforme.溶瘤腺病毒疗法治疗多形性胶质母细胞瘤
Neurosurg Focus. 2006 Apr 15;20(4):E19.

引用本文的文献

1
The Role of Mesenchymal Reprogramming in Malignant Clonal Evolution and Intra-Tumoral Heterogeneity in Glioblastoma.间质重编程在胶质母细胞瘤恶性克隆进化和肿瘤内异质性中的作用。
Cells. 2024 May 30;13(11):942. doi: 10.3390/cells13110942.
2
Eltanexor Effectively Reduces Viability of Glioblastoma and Glioblastoma Stem-Like Cells at Nano-Molar Concentrations and Sensitizes to Radiotherapy and Temozolomide.艾坦纳克索在纳摩尔浓度下可有效降低胶质母细胞瘤和胶质母细胞瘤样干细胞的活力,并使其对放疗和替莫唑胺敏感。
Biomedicines. 2022 Aug 31;10(9):2145. doi: 10.3390/biomedicines10092145.
3
Inhibition of Carbonic Anhydrase 2 Overcomes Temozolomide Resistance in Glioblastoma Cells.抑制碳酸酐酶 2 可克服脑胶质瘤细胞对替莫唑胺的耐药性。
Int J Mol Sci. 2021 Dec 23;23(1):157. doi: 10.3390/ijms23010157.
4
LncRNA MIR155HG Promotes Temozolomide Resistance by Activating the Wnt/β-Catenin Pathway Via Binding to PTBP1 in Glioma.长链非编码 RNA MIR155HG 通过与 PTBP1 结合激活 Wnt/β-连环蛋白通路促进脑胶质瘤替莫唑胺耐药
Cell Mol Neurobiol. 2021 Aug;41(6):1271-1284. doi: 10.1007/s10571-020-00898-z. Epub 2020 Jun 11.
5
Comparative Transcriptomic Analysis of Temozolomide Resistant Primary GBM Stem-Like Cells and Recurrent GBM Identifies Up-Regulation of the Carbonic Anhydrase Gene as Resistance Factor.替莫唑胺耐药的原发性胶质母细胞瘤干细胞样细胞与复发性胶质母细胞瘤的比较转录组分析确定碳酸酐酶基因上调为耐药因子。
Cancers (Basel). 2019 Jun 30;11(7):921. doi: 10.3390/cancers11070921.
6
Survivin a radiogenetic promoter for glioblastoma viral gene therapy independently from CArG motifs.存活素是一种用于胶质母细胞瘤病毒基因治疗的放射遗传启动子,独立于CArG基序。
Clin Transl Med. 2017 Dec;6(1):11. doi: 10.1186/s40169-017-0140-y. Epub 2017 Mar 1.
7
Glioma Stem Cells but Not Bulk Glioma Cells Upregulate IL-6 Secretion in Microglia/Brain Macrophages via Toll-like Receptor 4 Signaling.胶质瘤干细胞而非大部分胶质瘤细胞通过Toll样受体4信号上调小胶质细胞/脑巨噬细胞中白细胞介素-6的分泌。
J Neuropathol Exp Neurol. 2016 May;75(5):429-40. doi: 10.1093/jnen/nlw016. Epub 2016 Mar 30.
8
Isorhapontigenin suppresses growth of patient-derived glioblastoma spheres through regulating miR-145/SOX2/cyclin D1 axis.异丹叶大黄素通过调控miR-145/SOX2/细胞周期蛋白D1轴抑制患者来源的胶质母细胞瘤球体生长。
Neuro Oncol. 2016 Jun;18(6):830-9. doi: 10.1093/neuonc/nov298. Epub 2015 Dec 17.
9
Repurposing some older drugs that cross the blood-brain barrier and have potential anticancer activity to provide new treatment options for glioblastoma.重新利用一些能够穿过血脑屏障且具有潜在抗癌活性的老药,为胶质母细胞瘤提供新的治疗选择。
Br J Clin Pharmacol. 2016 Feb;81(2):199-209. doi: 10.1111/bcp.12785. Epub 2015 Oct 30.
10
Dendritic Cell-Based Vaccines that Utilize Myeloid Rather than Plasmacytoid Cells Offer a Superior Survival Advantage in Malignant Glioma.利用髓样细胞而非浆细胞样细胞的基于树突状细胞的疫苗在恶性胶质瘤中提供了更好的生存优势。
J Immunol. 2015 Jul 1;195(1):367-76. doi: 10.4049/jimmunol.1401607. Epub 2015 May 29.

本文引用的文献

1
Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivo.腺病毒病毒疗法与替莫唑胺化疗联合通过体内自噬和凋亡性细胞死亡根除恶性胶质瘤。
Br J Cancer. 2009 Apr 7;100(7):1154-64. doi: 10.1038/sj.bjc.6604969. Epub 2009 Mar 10.
2
Phase Ib trial of mutant herpes simplex virus G207 inoculated pre-and post-tumor resection for recurrent GBM.复发性胶质母细胞瘤患者在肿瘤切除前后接种突变型单纯疱疹病毒G207的Ib期试验。
Mol Ther. 2009 Jan;17(1):199-207. doi: 10.1038/mt.2008.228. Epub 2008 Oct 28.
3
Detection and characterization of CD133+ cancer stem cells in human solid tumours.人类实体瘤中CD133+癌症干细胞的检测与特性分析
PLoS One. 2008;3(10):e3469. doi: 10.1371/journal.pone.0003469. Epub 2008 Oct 21.
4
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions.实体瘤中的癌症干细胞:越来越多的证据与未解决的问题
Nat Rev Cancer. 2008 Oct;8(10):755-68. doi: 10.1038/nrc2499. Epub 2008 Sep 11.
5
Targeting cancer stem cells through L1CAM suppresses glioma growth.通过L1CAM靶向癌症干细胞可抑制胶质瘤生长。
Cancer Res. 2008 Aug 1;68(15):6043-8. doi: 10.1158/0008-5472.CAN-08-1079.
6
Low-dose radiation enhances survivin-mediated virotherapy against malignant glioma stem cells.低剂量辐射增强生存素介导的针对恶性胶质瘤干细胞的病毒疗法。
Cancer Res. 2008 Jul 15;68(14):5778-84. doi: 10.1158/0008-5472.CAN-07-6441.
7
Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer.不同的癌症干细胞群体决定了人类胰腺癌的肿瘤生长和转移活性。
Cell Stem Cell. 2007 Sep 13;1(3):313-23. doi: 10.1016/j.stem.2007.06.002.
8
A phase I trial of intratumoral administration of reovirus in patients with histologically confirmed recurrent malignant gliomas.一项针对组织学确诊的复发性恶性胶质瘤患者进行瘤内注射呼肠孤病毒的I期试验。
Mol Ther. 2008 Mar;16(3):627-32. doi: 10.1038/sj.mt.6300403. Epub 2008 Feb 5.
9
Identification and expansion of the tumorigenic lung cancer stem cell population.致瘤性肺癌干细胞群体的鉴定与扩增。
Cell Death Differ. 2008 Mar;15(3):504-14. doi: 10.1038/sj.cdd.4402283. Epub 2007 Nov 30.
10
Tumorigenesis of chemotherapeutic drug-resistant cancer stem-like cells in brain glioma.脑胶质瘤中化疗耐药癌干细胞样细胞的肿瘤发生
Stem Cells Dev. 2007 Oct;16(5):837-47. doi: 10.1089/scd.2007.0006.

病毒疗法对抗恶性神经胶质瘤干细胞。

Virotherapy against malignant glioma stem cells.

机构信息

The Brain Tumor Center, The University of Chicago, Chicago, IL, USA.

出版信息

Cancer Lett. 2010 Mar 1;289(1):1-10. doi: 10.1016/j.canlet.2009.04.045. Epub 2009 Jul 29.

DOI:10.1016/j.canlet.2009.04.045
PMID:19643532
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2824041/
Abstract

Glioblastoma multiforme, the most common primary intracranial malignancy, is associated with very poor outcome despite advances in surgical techniques and chemo- and radiation therapy. Many novel treatment modalities are being investigated with varying amount of success. Evolution of cancer stem cell hypothesis provides a new venue for developmental therapeutics. In this review, we highlight the literature regarding the existence of glioma stem cells and their characteristics. We also discuss the potential for virotherapy, a novel therapeutic approach utilizing conditionally replicative viruses, to directly target this population of self-renewing cancer stem cells.

摘要

多形性胶质母细胞瘤是最常见的原发性颅内恶性肿瘤,尽管在手术技术以及化疗和放疗方面取得了进展,但预后仍然很差。许多新的治疗方法正在研究中,取得了不同程度的成功。癌症干细胞假说的发展为开发治疗药物提供了新的途径。在这篇综述中,我们强调了关于神经胶质瘤干细胞的存在及其特征的文献。我们还讨论了病毒疗法的潜力,这是一种利用条件复制病毒的新型治疗方法,以直接针对这种自我更新的癌症干细胞群体。